John P. McLaughlin

2011

In 2011, John P. McLaughlin earned a total compensation of $1.2M as President and Chief Executive Officer at PDL BioPharma, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$368,550
Salary$585,000
Stock Awards$201,000
Other$9,800
Total$1,164,350

McLaughlin received $585K in salary, accounting for 50% of the total pay in 2011.

McLaughlin also received $368.6K in non-equity incentive plan, $201K in stock awards and $9.8K in other compensation.

Rankings

In 2011, John P. McLaughlin's compensation ranked 5,096th out of 10,747 executives tracked by ExecPay. In other words, McLaughlin earned more than 52.6% of executives.

ClassificationRankingPercentile
All
5,096
out of 10,747
53rd
Division
Manufacturing
1,840
out of 3,960
54th
Major group
Chemicals And Allied Products
388
out of 1,038
63rd
Industry group
Drugs
241
out of 786
69th
Industry
Biological Products, Except Diagnostic Substances
39
out of 162
76th
Source: SEC filing on April 17, 2014.

McLaughlin's colleagues

We found five more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2011.

2011

Christine Larson

PDL BioPharma

Chief Financial Officer

2011

Christopher Stone

PDL BioPharma

General Counsel

2011

Caroline Krumel

PDL BioPharma

Former Vice President of Finance and Principal Accounting Officer

2011

Danny Hart

PDL BioPharma

General Counsel

2011

Karen Wilson

PDL BioPharma

Former Vice President of Finance and Principal Accounting Officer

News

You may also like